非選択的アゴニストの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

• 英文タイトル：Global Nonselective Agonists Market 2019 by Company, Regions, Type and Application, Forecast to 2024

• レポートコード：B-GIR08C4044
• 出版社/出版日：GlobalInfoResearch / 2019年7月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、138ページ
• 納品方法：Eメール
• 産業分類：Pharma & Healthcare

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査レポートは、非選択的アゴニストの世界市場について調べ、まとめました。種類別セグメントは、アドレナリン、ノルアドレナリン、イソプレナリン、ドーパミン等、用途別セグメントは、等に区分しました。非選択的アゴニストの世界市場概観、企業動向、企業別非選択的アゴニストシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・非選択的アゴニストの市場概観
・非選択的アゴニストの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・非選択的アゴニストの企業別販売動向、市場シェア、市場集中度、競争動向
・非選択的アゴニストの世界市場規模
・非選択的アゴニストの北米市場分析（アメリカ、カナダ、メキシコ等）
・非選択的アゴニストのアメリカ市場規模推移
・非選択的アゴニストのカナダ市場規模推移
・非選択的アゴニストのメキシコ市場規模推移
・非選択的アゴニストのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・非選択的アゴニストのドイツ市場規模推移
・非選択的アゴニストのイギリス市場規模推移
・非選択的アゴニストのロシア市場規模推移
・非選択的アゴニストのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・非選択的アゴニストの日本市場規模推移
・非選択的アゴニストの中国市場規模推移
・非選択的アゴニストの韓国市場規模推移
・非選択的アゴニストのインド市場規模推移
・非選択的アゴニストの東南アジア市場規模推移
・非選択的アゴニストの南米市場分析（ブラジル、アルゼンチン等）
・非選択的アゴニストの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・非選択的アゴニストの種類別分析/販売量、売上、市場シェア（アドレナリン、ノルアドレナリン、イソプレナリン、ドーパミン）
・非選択的アゴニストの用途別分析/市場規模（）
・非選択的アゴニストの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・非選択的アゴニストの販売チャネル・代理店・貿易業者・ディーラー分析

Scope of the Report:
The global Nonselective Agonists market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Nonselective Agonists.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Nonselective Agonists market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Nonselective Agonists market by product type and applications/end industries.

Market Segment by Companies, this report covers
Pfizer
Sanofi
Novartis
Sterimax
Bedford Pharmaceuticals
Teva
Amneal Biosciences
Baxter Laboratories
Hikma Pharmaceuticals
Amphastar Pharmaceuticals
Marathon Pharmaceuticals
Bausch Health Companies
Sterling-Winthrop
Cipla USA
Nexus Pharmaceuticals
Mylan
Impax
ALK Abello
Lincoln Medical
Amphastar
Emerade
Grand Pharma
Harvest Pharmaceuticals
Merit Pharmaceutical
Tianjin Jinyao Group

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Adrenaline
Noradrenaline
Isoprenaline
Dopamine

Market Segment by Applications, can be divided into
Acute Hypotensive Shock
Peripheral Vasodilatation Shock
Bronchial Asthma
Atrioventricular Block
Anaphylaxis
Cardiac Arrest
Others

レポート目次

Table of Contents

1 Nonselective Agonists Market Overview
1.1 Product Overview and Scope of Nonselective Agonists
1.2 Classification of Nonselective Agonists by Types
1.2.1 Global Nonselective Agonists Revenue Comparison by Types (2019-2024)
1.2.2 Global Nonselective Agonists Revenue Market Share by Types in 2018
1.2.3 Adrenaline
1.2.4 Noradrenaline
1.2.5 Isoprenaline
1.2.6 Dopamine
1.3 Global Nonselective Agonists Market by Application
1.3.1 Global Nonselective Agonists Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Acute Hypotensive Shock
1.3.3 Peripheral Vasodilatation Shock
1.3.4 Bronchial Asthma
1.3.5 Atrioventricular Block
1.3.6 Anaphylaxis
1.3.7 Cardiac Arrest
1.3.8 Others
1.4 Global Nonselective Agonists Market by Regions
1.4.1 Global Nonselective Agonists Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Nonselective Agonists Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Nonselective Agonists Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nonselective Agonists Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Nonselective Agonists Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nonselective Agonists Status and Prospect (2014-2024)
1.5 Global Market Size of Nonselective Agonists (2014-2024)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Nonselective Agonists Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.2 Sanofi
2.2.1 Business Overview
2.2.2 Nonselective Agonists Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Nonselective Agonists Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.4 Sterimax
2.4.1 Business Overview
2.4.2 Nonselective Agonists Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sterimax Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.5 Bedford Pharmaceuticals
2.5.1 Business Overview
2.5.2 Nonselective Agonists Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bedford Pharmaceuticals Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.6 Teva
2.6.1 Business Overview
2.6.2 Nonselective Agonists Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Teva Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.7 Amneal Biosciences
2.7.1 Business Overview
2.7.2 Nonselective Agonists Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Amneal Biosciences Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.8 Baxter Laboratories
2.8.1 Business Overview
2.8.2 Nonselective Agonists Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Baxter Laboratories Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.9 Hikma Pharmaceuticals
2.9.1 Business Overview
2.9.2 Nonselective Agonists Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Hikma Pharmaceuticals Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.10 Amphastar Pharmaceuticals
2.10.1 Business Overview
2.10.2 Nonselective Agonists Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Amphastar Pharmaceuticals Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.11 Marathon Pharmaceuticals
2.11.1 Business Overview
2.11.2 Nonselective Agonists Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Marathon Pharmaceuticals Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.12 Bausch Health Companies
2.12.1 Business Overview
2.12.2 Nonselective Agonists Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Bausch Health Companies Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.13 Sterling-Winthrop
2.13.1 Business Overview
2.13.2 Nonselective Agonists Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Sterling-Winthrop Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.14 Cipla USA
2.14.1 Business Overview
2.14.2 Nonselective Agonists Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Cipla USA Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.15 Nexus Pharmaceuticals
2.15.1 Business Overview
2.15.2 Nonselective Agonists Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Nexus Pharmaceuticals Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.16 Mylan
2.16.1 Business Overview
2.16.2 Nonselective Agonists Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Mylan Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.17 Impax
2.17.1 Business Overview
2.17.2 Nonselective Agonists Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Impax Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.18 ALK Abello
2.18.1 Business Overview
2.18.2 Nonselective Agonists Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 ALK Abello Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.19 Lincoln Medical
2.19.1 Business Overview
2.19.2 Nonselective Agonists Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Lincoln Medical Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.20 Amphastar
2.20.1 Business Overview
2.20.2 Nonselective Agonists Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Amphastar Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.21 Emerade
2.21.1 Business Overview
2.2.2 Nonselective Agonists Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Emerade Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.22 Grand Pharma
2.22.1 Business Overview
2.22.2 Nonselective Agonists Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Grand Pharma Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.23 Harvest Pharmaceuticals
2.23.1 Business Overview
2.23.2 Nonselective Agonists Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Harvest Pharmaceuticals Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.24 Merit Pharmaceutical
2.24.1 Business Overview
2.24.2 Nonselective Agonists Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 Merit Pharmaceutical Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.25 Tianjin Jinyao Group
2.25.1 Business Overview
2.25.2 Nonselective Agonists Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 Tianjin Jinyao Group Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
3 Global Nonselective Agonists Market Competition, by Players
3.1 Global Nonselective Agonists Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Nonselective Agonists Players Market Share
3.2.2 Top 10 Nonselective Agonists Players Market Share
3.3 Market Competition Trend
4 Global Nonselective Agonists Market Size by Regions
4.1 Global Nonselective Agonists Revenue and Market Share by Regions
4.2 North America Nonselective Agonists Revenue and Growth Rate (2014-2019)
4.3 Europe Nonselective Agonists Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Nonselective Agonists Revenue and Growth Rate (2014-2019)
4.5 South America Nonselective Agonists Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Nonselective Agonists Revenue and Growth Rate (2014-2019)
5 North America Nonselective Agonists Revenue by Countries
5.1 North America Nonselective Agonists Revenue by Countries (2014-2019)
5.2 USA Nonselective Agonists Revenue and Growth Rate (2014-2019)
5.3 Canada Nonselective Agonists Revenue and Growth Rate (2014-2019)
5.4 Mexico Nonselective Agonists Revenue and Growth Rate (2014-2019)
6 Europe Nonselective Agonists Revenue by Countries
6.1 Europe Nonselective Agonists Revenue by Countries (2014-2019)
6.2 Germany Nonselective Agonists Revenue and Growth Rate (2014-2019)
6.3 UK Nonselective Agonists Revenue and Growth Rate (2014-2019)
6.4 France Nonselective Agonists Revenue and Growth Rate (2014-2019)
6.5 Russia Nonselective Agonists Revenue and Growth Rate (2014-2019)
6.6 Italy Nonselective Agonists Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Nonselective Agonists Revenue by Countries
7.1 Asia-Pacific Nonselective Agonists Revenue by Countries (2014-2019)
7.2 China Nonselective Agonists Revenue and Growth Rate (2014-2019)
7.3 Japan Nonselective Agonists Revenue and Growth Rate (2014-2019)
7.4 Korea Nonselective Agonists Revenue and Growth Rate (2014-2019)
7.5 India Nonselective Agonists Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Nonselective Agonists Revenue and Growth Rate (2014-2019)
8 South America Nonselective Agonists Revenue by Countries
8.1 South America Nonselective Agonists Revenue by Countries (2014-2019)
8.2 Brazil Nonselective Agonists Revenue and Growth Rate (2014-2019)
8.3 Argentina Nonselective Agonists Revenue and Growth Rate (2014-2019)
8.4 Colombia Nonselective Agonists Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Nonselective Agonists by Countries
9.1 Middle East and Africa Nonselective Agonists Revenue by Countries (2014-2019)
9.2 Saudi Arabia Nonselective Agonists Revenue and Growth Rate (2014-2019)
9.3 UAE Nonselective Agonists Revenue and Growth Rate (2014-2019)
9.4 Egypt Nonselective Agonists Revenue and Growth Rate (2014-2019)
9.5 Nigeria Nonselective Agonists Revenue and Growth Rate (2014-2019)
9.6 South Africa Nonselective Agonists Revenue and Growth Rate (2014-2019)
10 Global Nonselective Agonists Market Segment by Type
10.1 Global Nonselective Agonists Revenue and Market Share by Type (2014-2019)
10.2 Global Nonselective Agonists Market Forecast by Type (2019-2024)
10.3 Adrenaline Revenue Growth Rate (2014-2024)
10.4 Noradrenaline Revenue Growth Rate (2014-2024)
10.5 Isoprenaline Revenue Growth Rate (2014-2024)
10.6 Dopamine Revenue Growth Rate (2014-2024)
11 Global Nonselective Agonists Market Segment by Application
11.1 Global Nonselective Agonists Revenue Market Share by Application (2014-2019)
11.2 Nonselective Agonists Market Forecast by Application (2019-2024)
11.3 Acute Hypotensive Shock Revenue Growth (2014-2019)
11.4 Peripheral Vasodilatation Shock Revenue Growth (2014-2019)
11.5 Bronchial Asthma Revenue Growth (2014-2019)
11.6 Atrioventricular Block Revenue Growth (2014-2019)
11.7 Anaphylaxis Revenue Growth (2014-2019)
11.8 Cardiac Arrest Revenue Growth (2014-2019)
11.9 Others Revenue Growth (2014-2019)
12 Global Nonselective Agonists Market Size Forecast (2019-2024)
12.1 Global Nonselective Agonists Market Size Forecast (2019-2024)
12.2 Global Nonselective Agonists Market Forecast by Regions (2019-2024)
12.3 North America Nonselective Agonists Revenue Market Forecast (2019-2024)
12.4 Europe Nonselective Agonists Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Nonselective Agonists Revenue Market Forecast (2019-2024)
12.6 South America Nonselective Agonists Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Nonselective Agonists Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Nonselective Agonists Picture
Table Product Specifications of Nonselective Agonists
Table Global Nonselective Agonists and Revenue (Million USD) Market Split by Product Type
Figure Global Nonselective Agonists Revenue Market Share by Types in 2018
Figure Adrenaline Picture
Figure Noradrenaline Picture
Figure Isoprenaline Picture
Figure Dopamine Picture
Table Global Nonselective Agonists Revenue (Million USD) by Application (2014-2024)
Figure Nonselective Agonists Revenue Market Share by Applications in 2018
Figure Acute Hypotensive Shock Picture
Figure Peripheral Vasodilatation Shock Picture
Figure Bronchial Asthma Picture
Figure Atrioventricular Block Picture
Figure Anaphylaxis Picture
Figure Cardiac Arrest Picture
Figure Others Picture
Table Global Market Nonselective Agonists Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Nonselective Agonists Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Nonselective Agonists Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Nonselective Agonists Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Nonselective Agonists Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Nonselective Agonists Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Nonselective Agonists Revenue (Million USD) and Growth Rate (2014-2024)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Nonselective Agonists Type and Applications
Table Pfizer Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Nonselective Agonists Type and Applications
Table Sanofi Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Nonselective Agonists Type and Applications
Table Novartis Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Sterimax Basic Information, Manufacturing Base and Competitors
Table Sterimax Nonselective Agonists Type and Applications
Table Sterimax Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Bedford Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Bedford Pharmaceuticals Nonselective Agonists Type and Applications
Table Bedford Pharmaceuticals Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Nonselective Agonists Type and Applications
Table Teva Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Amneal Biosciences Basic Information, Manufacturing Base and Competitors
Table Amneal Biosciences Nonselective Agonists Type and Applications
Table Amneal Biosciences Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Baxter Laboratories Basic Information, Manufacturing Base and Competitors
Table Baxter Laboratories Nonselective Agonists Type and Applications
Table Baxter Laboratories Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Hikma Pharmaceuticals Nonselective Agonists Type and Applications
Table Hikma Pharmaceuticals Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Amphastar Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Amphastar Pharmaceuticals Nonselective Agonists Type and Applications
Table Amphastar Pharmaceuticals Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Marathon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Marathon Pharmaceuticals Nonselective Agonists Type and Applications
Table Marathon Pharmaceuticals Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Bausch Health Companies Basic Information, Manufacturing Base and Competitors
Table Bausch Health Companies Nonselective Agonists Type and Applications
Table Bausch Health Companies Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Sterling-Winthrop Basic Information, Manufacturing Base and Competitors
Table Sterling-Winthrop Nonselective Agonists Type and Applications
Table Sterling-Winthrop Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Cipla USA Basic Information, Manufacturing Base and Competitors
Table Cipla USA Nonselective Agonists Type and Applications
Table Cipla USA Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Nexus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Nexus Pharmaceuticals Nonselective Agonists Type and Applications
Table Nexus Pharmaceuticals Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Nonselective Agonists Type and Applications
Table Mylan Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Impax Basic Information, Manufacturing Base and Competitors
Table Impax Nonselective Agonists Type and Applications
Table Impax Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table ALK Abello Basic Information, Manufacturing Base and Competitors
Table ALK Abello Nonselective Agonists Type and Applications
Table ALK Abello Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Lincoln Medical Basic Information, Manufacturing Base and Competitors
Table Lincoln Medical Nonselective Agonists Type and Applications
Table Lincoln Medical Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Amphastar Basic Information, Manufacturing Base and Competitors
Table Amphastar Nonselective Agonists Type and Applications
Table Amphastar Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Emerade Basic Information, Manufacturing Base and Competitors
Table Emerade Nonselective Agonists Type and Applications
Table Emerade Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Grand Pharma Basic Information, Manufacturing Base and Competitors
Table Grand Pharma Nonselective Agonists Type and Applications
Table Grand Pharma Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Harvest Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Harvest Pharmaceuticals Nonselective Agonists Type and Applications
Table Harvest Pharmaceuticals Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Merit Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Merit Pharmaceutical Nonselective Agonists Type and Applications
Table Merit Pharmaceutical Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Tianjin Jinyao Group Basic Information, Manufacturing Base and Competitors
Table Tianjin Jinyao Group Nonselective Agonists Type and Applications
Table Tianjin Jinyao Group Nonselective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Global Nonselective Agonists Revenue (Million USD) by Players (2014-2019)
Table Global Nonselective Agonists Revenue Share by Players (2014-2019)
Figure Global Nonselective Agonists Revenue Share by Players in 2017
Figure Global Nonselective Agonists Revenue Share by Players in 2018
Figure Global Top 5 Players Nonselective Agonists Revenue Market Share in 2018
Figure Global Top 10 Players Nonselective Agonists Revenue Market Share in 2018
Figure Global Nonselective Agonists Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Nonselective Agonists Revenue (Million USD) by Regions (2014-2019)
Table Global Nonselective Agonists Revenue Market Share by Regions (2014-2019)
Figure Global Nonselective Agonists Revenue Market Share by Regions (2014-2019)
Figure Global Nonselective Agonists Revenue Market Share by Regions in 2018
Figure North America Nonselective Agonists Revenue and Growth Rate (2014-2019)
Figure Europe Nonselective Agonists Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Nonselective Agonists Revenue and Growth Rate (2014-2019)
Figure South America Nonselective Agonists Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Nonselective Agonists Revenue and Growth Rate (2014-2019)
Table North America Nonselective Agonists Revenue by Countries (2014-2019)
Table North America Nonselective Agonists Revenue Market Share by Countries (2014-2019)
Figure North America Nonselective Agonists Revenue Market Share by Countries (2014-2019)
Figure North America Nonselective Agonists Revenue Market Share by Countries in 2018
Figure USA Nonselective Agonists Revenue and Growth Rate (2014-2019)
Figure Canada Nonselective Agonists Revenue and Growth Rate (2014-2019)
Figure Mexico Nonselective Agonists Revenue and Growth Rate (2014-2019)
Table Europe Nonselective Agonists Revenue (Million USD) by Countries (2014-2019)
Figure Europe Nonselective Agonists Revenue Market Share by Countries (2014-2019)
Figure Europe Nonselective Agonists Revenue Market Share by Countries in 2018
Figure Germany Nonselective Agonists Revenue and Growth Rate (2014-2019)
Figure UK Nonselective Agonists Revenue and Growth Rate (2014-2019)
Figure France Nonselective Agonists Revenue and Growth Rate (2014-2019)
Figure Russia Nonselective Agonists Revenue and Growth Rate (2014-2019)
Figure Italy Nonselective Agonists Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Nonselective Agonists Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Nonselective Agonists Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Nonselective Agonists Revenue Market Share by Countries in 2018
Figure China Nonselective Agonists Revenue and Growth Rate (2014-2019)
Figure Japan Nonselective Agonists Revenue and Growth Rate (2014-2019)
Figure Korea Nonselective Agonists Revenue and Growth Rate (2014-2019)
Figure India Nonselective Agonists Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Nonselective Agonists Revenue and Growth Rate (2014-2019)
Table South America Nonselective Agonists Revenue by Countries (2014-2019)
Table South America Nonselective Agonists Revenue Market Share by Countries (2014-2019)
Figure South America Nonselective Agonists Revenue Market Share by Countries (2014-2019)
Figure South America Nonselective Agonists Revenue Market Share by Countries in 2018
Figure Brazil Nonselective Agonists Revenue and Growth Rate (2014-2019)
Figure Argentina Nonselective Agonists Revenue and Growth Rate (2014-2019)
Figure Colombia Nonselective Agonists Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Nonselective Agonists Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Nonselective Agonists Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Nonselective Agonists Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Nonselective Agonists Revenue Market Share by Countries in 2018
Figure Saudi Arabia Nonselective Agonists Revenue and Growth Rate (2014-2019)
Figure UAE Nonselective Agonists Revenue and Growth Rate (2014-2019)
Figure Egypt Nonselective Agonists Revenue and Growth Rate (2014-2019)
Figure Nigeria Nonselective Agonists Revenue and Growth Rate (2014-2019)
Figure South Africa Nonselective Agonists Revenue and Growth Rate (2014-2019)
Table Global Nonselective Agonists Revenue (Million USD) by Type (2014-2019)
Table Global Nonselective Agonists Revenue Share by Type (2014-2019)
Figure Global Nonselective Agonists Revenue Share by Type (2014-2019)
Figure Global Nonselective Agonists Revenue Share by Type in 2018
Table Global Nonselective Agonists Revenue Forecast by Type (2019-2024)
Figure Global Nonselective Agonists Market Share Forecast by Type (2019-2024)
Figure Global Adrenaline Revenue Growth Rate (2014-2019)
Figure Global Noradrenaline Revenue Growth Rate (2014-2019)
Figure Global Isoprenaline Revenue Growth Rate (2014-2019)
Figure Global Dopamine Revenue Growth Rate (2014-2019)
Table Global Nonselective Agonists Revenue by Application (2014-2019)
Table Global Nonselective Agonists Revenue Share by Application (2014-2019)
Figure Global Nonselective Agonists Revenue Share by Application (2014-2019)
Figure Global Nonselective Agonists Revenue Share by Application in 2018
Table Global Nonselective Agonists Revenue Forecast by Application (2019-2024)
Figure Global Nonselective Agonists Market Share Forecast by Application (2019-2024)
Figure Global Acute Hypotensive Shock Revenue Growth Rate (2014-2019)
Figure Global Peripheral Vasodilatation Shock Revenue Growth Rate (2014-2019)
Figure Global Bronchial Asthma Revenue Growth Rate (2014-2019)
Figure Global Atrioventricular Block Revenue Growth Rate (2014-2019)
Figure Global Anaphylaxis Revenue Growth Rate (2014-2019)
Figure Global Cardiac Arrest Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Nonselective Agonists Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Nonselective Agonists Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Nonselective Agonists Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Nonselective Agonists Revenue Market Forecast (2019-2024)
Figure Europe Nonselective Agonists Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Nonselective Agonists Revenue Market Forecast (2019-2024)
Figure South America Nonselective Agonists Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Nonselective Agonists Revenue Market Forecast (2019-2024)

Global β1 Adrenoceptor Agonists Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C6508 2019年7月 123Pages
本調査レポートは、β1アドレナリン受容体作動薬の世界市場について調べ、まとめました。種類別セグメントは、ドブタミン、デノパミン、ザモテロール、その他等、用途別セグメントは、等に区分しました。β1アドレナリン受容体作動薬の世界市場概観、企業動向、企業別β1アドレナリン受容体作動薬シェア、市場規模推移、...

β2アドレナリン受容体作動薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global β2 Adrenoceptor Agonists Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C6509 2019年7月 136Pages
本調査レポートは、β2アドレナリン受容体作動薬の世界市場について調べ、まとめました。種類別セグメントは、アルブテロール、テルブタリン、サルメテロール、ホルモテロール、ピルブテロール等、用途別セグメントは、等に区分しました。β2アドレナリン受容体作動薬の世界市場概観、企業動向、企業別β2アドレナリン受...

選択的アゴニストの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Selective Agonists Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C5100 2019年7月 136Pages
本調査レポートは、選択的アゴニストの世界市場について調べ、まとめました。種類別セグメントは、α1選択的アゴニスト、α2選択的アゴニスト、β1選択的アゴニスト、β2選択的アゴニスト等、用途別セグメントは、等に区分しました。選択的アゴニストの世界市場概観、企業動向、企業別選択的アゴニストシェア、市場規模...

βアドレナリン受容体作動薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global β Adrenoceptor Agonists Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C6507 2019年7月 139Pages
本調査レポートは、βアドレナリン受容体作動薬の世界市場について調べ、まとめました。種類別セグメントは、イソプレナリン、ドブタミン、サルブタモール、テルブタリン、サルメテロール、ホルモテロール、ピルブテロール等、用途別セグメントは、等に区分しました。βアドレナリン受容体作動薬の世界市場概観、企業動向、...

便秘治療薬の世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global Constipation Treatment Drug Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C1451 2019年8月 136Pages
本調査レポートは、便秘治療薬の世界市場について調べ、まとめました。種類別セグメントは、下剤、塩化物チャネル活性化剤、5-HT 4受容体作動薬、GC-C作動薬、末梢作用ミューオピオイド受容体拮抗薬等、用途別セグメントは、小売薬局、病院薬局、オンライン薬局等に区分しました。便秘治療薬の世界市場概観、企業...

オピオイド耐性治療の世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global Opioid Tolerance Treatment Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C4147 2019年8月 120Pages
本調査レポートは、オピオイド耐性治療の世界市場について調べ、まとめました。種類別セグメントは、NMDA拮抗薬、α2 - アドレナリン受容体作動薬等、用途別セグメントは、病院・外来手術センター、リハビリテーションセンター等に区分しました。オピオイド耐性治療の世界市場概観、企業動向、企業別オピオイド耐性...

5Gアプリケーション及びサービスの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global 5G Applications and Services Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C6585 2019年7月 136Pages
本調査レポートは、5Gアプリケーション及びサービスの世界市場について調べ、まとめました。種類別セグメントは、エンハンストモバイルブロードバンド、超高信頼性低遅延通信、大規模マシン型通信、固定無線アクセス、その他等、用途別セグメントは、等に区分しました。5Gアプリケーション及びサービスの世界市場概観、...

照明用白色LEDの世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global White LEDs for Lighting Applications Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C6381 2019年8月 122Pages
本調査レポートは、照明用白色LEDの世界市場について調べ、まとめました。種類別セグメントは、懐中電灯、シーリングライト、プロジェクションランプ、その他等、用途別セグメントは、公用、家庭用等に区分しました。照明用白色LEDの世界市場概観、企業動向、企業別照明用白色LEDシェア、市場規模推移、市場規模予...

衣類ファスナーの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Clothing Fasteners Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C1291 2019年7月 137Pages
本調査レポートは、衣類ファスナーの世界市場について調べ、まとめました。種類別セグメントは、ジッパー、ボタン、スナップ、その他等、用途別セグメントは、等に区分しました。衣類ファスナーの世界市場概観、企業動向、企業別衣類ファスナーシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析...

医薬のRFIDの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global RFID in Pharmaceuticals Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C4950 2019年7月 136Pages
本調査レポートは、医薬のRFIDの世界市場について調べ、まとめました。種類別セグメントは、RFIDリーダー、RFIDタグ、RFIDミドルウェア等、用途別セグメントは、等に区分しました。医薬のRFIDの世界市場概観、企業動向、企業別医薬のRFIDシェア、市場規模推移、市場規模予測（2019年-2024...

β1アドレナリン受容体作動薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global β1 Adrenoceptor Agonists market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, …
βアドレナリン受容体作動薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global β Adrenoceptor Agonists market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, a…
β2アドレナリン受容体作動薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global β2 Adrenoceptor Agonists market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, …
選択的アゴニストの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Selective Agonists market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also f…
便秘治療薬の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Constipation Treatment Drug is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Constipation Treatmen…